Evaluation of Extracorporal Shockwave Therapy (ESWT) in Achilles tendinopathy using Shear Wave Elastography (SWE) and Ultrasound Tissue Characterisation (UTC): a single-blinded, placebo-controlled randomised clinical trial.

Not Applicable

• Conditions: M76.6; Achilles tendinitis

• Registration Number: DRKS00014594
• Lead Sponsor: niversitätsklinikum AachenKlinik für Orthopädie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-14
• Study Completion: 2019-10-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Achilles tendinopathy with symptoms at least for 3 months

Exclusion Criteria

pregnancy, underage, under- weight and overweight (BMI>35, BMI <17), injections with cortison or other substances in the last 6 months or planned injections in the followin 6 months, operations on the Achilles tendon. Explicit contraindications for usage of ESWT are malignt tumors in the area of pain as well as an bacterial oseteomyelitis.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
6 month: pain scores (VISA-A Score, AOFAS Score, Likert Scale, Roles and Maudesly Score) // B-Mode (tendon thickness, hypoechogenity, calcification, morphology (fusiform etc.), echo pattern) // PowerDoppler (Öhberg Score) // ShearWaveElastograhy (SWE) (mean SWE values (ins. + mid-portion) // Ultrasound Tissue Characterisation (UTC) (percentage distribution of echo types)

Secondary Outcome Measures

Name	Time	Method
6 weeks: pain scores (VISA-A Score, AOFAS Score, Likert Scale, Roles and Maudesly Score) // B-Mode (tendon thickness, hypoechogenity, calcification, morphology (fusiform etc.), echo pattern) // PowerDoppler (Öhberg Score) // ShearWaveElastograhy (SWE) (mean SWE values (ins. + mid-portion) // Ultrasound Tissue Characterisation (UTC) (percentage distribution of echo types)